Personen
Moritz Spangemacher
Arzt | Doktorand | Wissenschaftlicher Mitarbeiter

Abteilung Molekulares Neuroimaging
Publikationen in peer-reviewed Zeitschriften seit 2006
TOP 5 Publikationen:
- , , , , . Compassionate use of psilocybin for treatment-resistant depression in Germany.Lancet Psychiatry. 2025 Sep 18. [Epub ahead of print].
- , , , , , , , . Treatment with psychedelics is psychotherapy: beyond reductionism.Lancet Psychiatry. 2024 11(3):231-236. Epub 2023 Dec 12.
- , , , , , . Psilocybin as a Disease-Modifying Drug—a Salutogenic Approach in Psychiatry.Dtsch Arztebl Int. 2024 121(26):868-874. Epub 2024 Dec 27.
- , , , , , , , , , , , . Baseline monocyte count predicts symptom improvement during intravenous ketamine therapy in treatment-resistant depression: a single-arm open-label observational study.Front Psychiatry. 2024 15:1415505.
- , , , , , , , . Association between rTMS-induced changes in inflammatory markers and improvement in psychiatric diseases: a systematic review.Ann Gen Psychiatry. 2024 23(1):31.
Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de